$0.00 $0.00 (0.0%)

12:00 AM EST on 01/01/01

Plus Therapeutics Inc (NASDAQ:CYTX)

CAPS Rating: No stars

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Current Price $0.00 Mkt Cap $0.00
Open $0.00 P/E Ratio 0.00
Prev. Close $0.00 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume
52-Wk Range $0.00 - $0.00 Avg. Daily Vol.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

177 Outperform
31 Underperform
 

All-Star Players

14 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CYTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JGGardner (< 20)
Submitted February 17, 2010

The Regenerative Medicine market is expected to grow to $3 billion by 2015. Cytori Therapeutics (CYTX) is the early leader in this market and is now treating, on a daily basis, more patients than any competing stem cell company. Given the large… More

NeroSagetrade (51.70)
Submitted February 12, 2008

What a staggeringly STAGGERINGLY bad company! The numbers are absolutely obstrusive. These guys could write a book on how to lose money and it would be a best seller. Cytori has lost a whopping 52M in the last 2 years and is sitting on less than 30M… More

NASDAQ:CYTX VS S&P 500 (SPY)

Fools bullish on NASDAQ:CYTX are also bullish on:

Fools bearish on NASDAQ:CYTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CYTX.

Recs

0
Member Avatar BillStacker (< 20) Submitted: 7/3/2013 9:07:52 PM : Outperform Start Price: $35.70 NASDAQ:CYTX Score: -200.70

Made a good move with the new loan to sustain them for a while. I think the stock has bottomed and is ready to rebound.

Recs

0
Member Avatar vxfrbeva (< 20) Submitted: 2/3/2012 3:20:29 PM : Outperform Start Price: $63.00 NASDAQ:CYTX Score: -243.07

Cytori Therapeutics is inmerse in a big moment right now. Their bussines is going to get huge as there is a big market for the stem cells applied to heart recovery after heart atacks and also for the breasts surgery.

Recs

0
Member Avatar englishdk (< 20) Submitted: 12/7/2011 7:50:24 AM : Underperform Start Price: $38.55 NASDAQ:CYTX Score: +259.34

stem cells dont work

Leaderboard

Find the members with the highest scoring picks in CYTX.

Score Leader

hwyman64

hwyman64 (< 20) Score: +336.47

In time this stock will be worth worth actually sinking some money into.....not quite ready to join the bandwagon yet though.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
hwyman64 < 20 10/9/2008 Underperform 1Y $59.85 -99.65% +236.81% +336.47 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $49.80 -99.58% +214.06% +313.64 0 Comment
Korodas 67.57 9/1/2010 Underperform NS $71.55 -99.71% +201.94% +301.65 0 Comment
udlilmike 85.71 2/2/2010 Underperform 1Y $105.60 -99.80% +199.31% +299.12 0 Comment
UltraContrarian 31.05 11/12/2009 1/25/2010 Underperform 5Y $50.85 -99.59% +199.04% +298.63 0 Comment
smax1980 25.87 12/8/2009 Underperform 5Y $92.10 -99.77% +197.92% +297.70 0 Comment
longtermgrowth09 26.48 12/17/2009 Underperform 5Y $92.10 -99.77% +195.37% +295.14 0 Comment
GoldDontGlitter 97.76 12/7/2009 Underperform 5Y $93.45 -99.78% +194.86% +294.64 0 Comment
39272x2 30.87 12/1/2009 Underperform 5Y $90.00 -99.77% +194.83% +294.60 0 Comment
SwingingBridge 97.19 12/11/2009 Underperform 5Y $99.00 -99.79% +194.33% +294.12 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CYTX.